Scholar Rock Holding Corp [SRRK] stock is trading at $39.46, down -3.73%. An important factor to consider is whether the stock is rising or falling in short-term value. The SRRK shares have gain 5.31% over the last week, with a monthly amount glided 23.93%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Scholar Rock Holding Corp [NASDAQ: SRRK] stock has seen the most recent analyst activity on October 09, 2025, when BofA Securities initiated its Buy rating and assigned the stock a price target of $53. Previously, Barclays started tracking the stock with Overweight rating on September 17, 2025, and set its price target to $45. On September 15, 2025, Leerink Partners initiated with a Outperform rating and assigned a price target of $51 on the stock. In a note dated November 26, 2024, H.C. Wainwright reiterated a Buy rating on this stock and boosted its target price from $40 to $50.
Scholar Rock Holding Corp [SRRK] stock has fluctuated between $22.71 and $46.98 over the past year. Currently, Wall Street analysts expect the stock to reach $49.33 within the next 12 months. Scholar Rock Holding Corp [NASDAQ: SRRK] shares were valued at $39.46 at the most recent close of the market. An investor can expect a potential return of 25.01% based on the average SRRK price forecast.
Analyzing the SRRK fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.93, Equity is -1.27 and Total Capital is -1.12. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.26.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Scholar Rock Holding Corp’s Current Ratio is 6.33. On the other hand, the Quick Ratio is 6.33, and the Cash Ratio is 3.03.
Transactions by insiders
Recent insider trading involved AKKARAJU SRINIVAS, Director, that happened on Oct 03 ’25 when 0.39 million shares were purchased. Director, AKKARAJU SRINIVAS completed a deal on Oct 06 ’25 to buy 0.11 million shares. Meanwhile, CHIEF SCIENTIFIC OFFICER Qatanani Mo sold 3353.0 shares on Sep 22 ’25.
